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During persistent viral infection, adaptive immune
responses are suppressed by immunoregulatory
factors, contributing to viral persistence. Although
this suppression is mediated by inhibitory factors,
the mechanisms by which virus-specific T cells
encounter and integrate immunoregulatory signals
during persistent infection are unclear. We show
that a distinct population of IL-10-expressing immu-
noregulatory antigen-presenting cells (APCs) is
amplified during chronic versus acute lymphocytic
choriomeningitis virus (LCMV) infection and sup-
presses T cell responses. Although acute LCMV
infection induces the expansion of immunoregula-
tory APCs, they subsequently decline. However,
during persistent LCMV infection, immunoregulatory
APCs are amplified and parallel the viral replication
kinetics. Further characterization demonstrates that
immunoregulatory APCs are molecularly and meta-
bolically distinct, and exhibit increased expression
of T cell-interacting molecules and negative regula-
tory factors that suppress T cell responses. Thus,
immunoregulatory APCs are amplified during viral
persistence and deliver inhibitory signals that sup-
press antiviral T cell immunity and likely contribute
to persistent infection.
INTRODUCTION
The immune system resolves the majority of viral infections
through a concerted effort of both innate and adaptive mecha-
nisms. These multifaceted responses result in effective elimina-
tion of viral pathogens and the establishment of long-lasting
protective immunity. However, some viruses, including human
immunodeficiency virus (HIV) and hepatitis C virus (HCV) in
humans and lymphocytic choriomeningitis virus (LCMV) in
mice, are capable of enduring the initial immune onslaught andCell Hestablishing persistent infections (Klenerman and Hill, 2005;
Wilson and Brooks, 2010). The prolonged and elevated viral
titers associated with these types of infection progressively alter
T cell responses in a phenomenon known as exhaustion (Fahey
and Brooks, 2010). While immune exhaustion is counterproduc-
tive to viral clearance, it is likely necessary to prevent harmful
bystander immunopathology that is associated with prolonged
T cell responses in the face of unresolved high-level virus replica-
tion (Barber et al., 2006; Yi et al., 2009). Exhausted T cell
responses have a unique developmental program characterized
by decreased proliferation and the diminished ability to produce
antiviral and immunostimulatory cytokines that are associated
with acute viral infections (Fahey et al., 2011; Wherry et al.,
2003; Wherry et al., 2007). Importantly, some degree of lingering
T cell activity is actively maintained in persistent infection, and
while these residual responses differ in cytokine production
and magnitude from what is considered to be fully productive
antiviral T cell responses, they are critical for the long-term
control of viral replication (Agnellini et al., 2007; Elsaesser
et al., 2009; Fahey et al., 2011; Frohlich et al., 2009; Yi et al.,
2009). Thus, elucidating the control mechanisms that modulate
T cell responses will be important toward understanding how
these pathogens subvert the immune response to persist.
At the onset of an infection, T cells are primed by specialized
antigen-presenting cells (APCs) called dendritic cells (DCs)
(Banchereau and Steinman, 1998). During the initial priming,
multiple interactions, including signals from surface-bound and
soluble costimulatory and/or inhibitory molecules, function in
concert to stimulate and fine-tune T cell responses. However,
since these initial interactions cannot forecast the long-term
immune requirements needed to fight a particular infection,
cellular responses are pliant to local signals, and T cell functions
are continually modulated in response to the needs of the current
antigenic environment (Brooks et al., 2006a). As a result, multiple
APCs (including macrophages and B cells) and infected cell
populations (Mueller et al., 2007) that are not potent inducers
of T cell activation likely have important roles in the modulation
of the immune response as infection progresses. This is particu-
larly relevant during persistent infections both early, as the
initially productive T cell responses are suppressed, as well as
during viral persistence to modulate T cell activity and protectost & Microbe 11, 481–491, May 17, 2012 ª2012 Elsevier Inc. 481
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(Barber et al., 2006; Brooks et al., 2006b).
The host-derived immunoregulatory cytokine IL-10 is crucial in
driving T cell exhaustion and viral persistence following LCMV
infection (Brooks et al., 2006b; Ejrnaes et al., 2006). Early disrup-
tion of IL-10-mediated suppression prevents the loss of T cell
activity in response to an otherwise persistent LCMV infection
leading to rapid virus clearance (Brooks et al., 2006b; Ejrnaes
et al., 2006). Similarly, elevated IL-10 levels correlate with HIV
replication in humans, and recently a link between IL-10 expres-
sion and transition into persistent HCV infection was identified
(Brockman et al., 2009; Flynn et al., 2011). Ex vivo IL-10 blockade
enhanced anti-HIV and anti-HCV T cell activity (Clerici et al.,
1994; Landay et al., 1996; Rigopoulou et al., 2005), further indi-
cating the important and conserved suppressive role of IL-10
during many persistent virus infections.
In addition to IL-10, multiple immunoregulatory pathways
actively, simultaneously, and increasingly suppress T cell activity
during viral persistence, including PDL1/PD1, Lag3, Tim3,
CTLA4, indoleamine 2,3 dioxygenase (IDO), and TGF-b (Wilson
and Brooks, 2011). Consistent with graded levels of T cell
exhaustion, wherein increasing amounts of inhibitory signals in
combination achieve a threshold necessary for functional T cell
suppression, the concurrent blockade of multiple suppressive
signals additively enhances antiviral T cell activity (Blackburn
et al., 2009; Brooks et al., 2008; Jin et al., 2010). Yet, it is unclear
how the concurrent inhibitory signals needed to achieve the
suppressive threshold are delivered to a specific T cell in the
context of an overwhelming virus infection and inflammatory
environment. Herein we identify specific populations of immuno-
regulatory APCs (which for simplicity in nomenclature will
be called iAPCs) that simultaneously produce multiple T cell-
interacting and immune-inhibitory molecules to suppress anti-
viral T cell activity. Consistent with the expression of suppressive
factors, iAPCs are invoked by virus replication but rapidly wane
in the stimulatory environment of an acute infection. Conversely,
iAPCs are potentiated and highly amplified during persistent
infection to facilitate dampening of T cell responses and mainte-
nance of the suppressive environment. Thus, the amplification
and clustering of multiple immunoregulatory factors on a single
iAPC is a mechanism to simultaneously deliver potent inhibitory
signals and in a single interaction tip the balance toward ex-
hausted T cell responses and viral persistence.
RESULTS
Enhanced IL-10 Production during Viral Persistence Is
Primarily of Hematopoietic Origin
To elucidate the dynamics of IL-10 expression in viral infection,
we utilized the LCMV model system. Infection with the Arm-
strong (Arm) variant of LCMV induces robust CD4 and CD8
T cell responses that clear the virus within the first 2 weeks after
infection. Alternatively, the Clone 13 (Cl 13) variant of LCMV
replicates to substantially higher titers and, although initially
inducing productive T cell responses, rapidly elicits the expres-
sion of multiple host immunoregulatory factors that suppress
T cell activity to generate a persistent infection (Ahmed et al.,
1984; Wilson and Brooks, 2011). A unique aspect of the LCMV
system is the ability to directly compare an acute and persistent482 Cell Host & Microbe 11, 481–491, May 17, 2012 ª2012 Elsevier Iinfection with the same virus, allowing for the differentiation of
factors that are increased and important in persistent infection
from those that are the result of a common response to viral
infection.
To specifically characterize mechanisms of IL-10-mediated
immunosuppression, we utilized the Vert-X IL-10 reporter mouse
which expresses green fluorescent protein (GFP) linked by an
internal ribosome sequence (IRES) to the IL-10 locus (Madan
et al., 2009). Vert-X mice allow for direct identification of IL-
10-expressing cells without in vitro manipulation or cell fixation.
Regulation of IL-10 expression is not perturbed in these mice,
and the course of LCMV infection in this strain is analogous to
WT mice (data not shown). Importantly, IL-10 RNA and protein
expression was dramatically elevated in the GFP+ cells (see
Figure S1 online). Additionally, analyses described herein were
confirmed using a second IL-10 reporter (10BiT) mouse
(Maynard et al., 2007). The 10BiT mouse contains a bacterial
artificial chromosome (BAC) with a Thy1.1 reporter cassette in-
serted in-frame in the first exon of the IL-10 locus along with
a stop codon, thus enabling identification of IL-10-expressing
cells without any manipulation of the two functioning (i.e., no
IRES) endogenous IL-10 genes. All data were reproducible and
analogous in the 10BiT mice (data not shown).
IL-10 protein was detectible in the plasma from both Arm- and
Cl13-infected mice at early time points; however, upon the
resolution of acute infection, IL-10 levels wane, whereas they
remain elevated throughout the course of a persistent infection
(Figure 1A). While many cell types can produce and respond to
IL-10 in varying situations, the relevant sources in persistent viral
infection are still controversial (Wilson and Brooks, 2011). To
begin to define the relevant sources of IL-10 in persistent infec-
tion, we generated reciprocal mixed bone marrow chimeras of
B6- and IL-10-deficient mice. Following persistent Cl13 infec-
tion, plasma IL-10 levels were elevated only when the hemato-
poietic compartment was IL-10 sufficient (Figure 1B). On the
other hand, IL-10 levels were low to undetectable when the
hematopoietic compartment was derived from IL-10-deficient
mice, despite the rest of the mouse being IL-10 sufficient, indi-
cating that the induction of IL-10 during viral persistence is
predominantly from hematopoietic-derived cells. Production of
IL-10 from hematopoietically derived cells was elevated in
multiple organs throughout persistent compared to acute infec-
tion (Figures 1C and 1D). GFP+ gates were based on control
nontransgenic B6 mice (Figure S1). Interestingly, the absolute
number of GFP-expressing cells was elevated in persistent
infection, despite the overall decrease in splenic cellularity rela-
tive to acute infection (Arm, 3.9 3 107 ± 1.2 3 107, versus Cl13,
2.53 107 ± 93 106; p = 0.02). In other tissues, the percentage of
IL-10-expressing cells was elevated during persistent compared
to acute infection, but the lower overall levels of cellularity during
persistent infection led to equal overall numbers of iAPC
(Figure 1D). Levels of IL-10-expressing cells rose and peaked
in the spleen around day 9 after LCMV-Cl 13 infection (Figures
1C and 1D) in conjunction with the transition from functional
to exhausted T cell responses (Brooks et al., 2006a). IL-
10-expressing cells in the lymph nodes and in multiple nonlym-
phoid organs were initially lower, but then maintained or
increased through persistent infection, whereas they remained
low in acute infection (Figures 1C and 1D).nc.
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Figure 1. IL-10 Production during Viral
Persistence Is Primarily of Hematopoietic
Origin
(A) Kinetics of IL-10 protein concentration in the
plasma at the indicated days after LCMV Arm (red)
or LCMV CL13 (black) infection of Vert-X mice.
(B) Bonemarrow chimeric mice were generated by
irradiating recipient mice (red) and reconstituting
with donor bone marrow (black). Nonirradiated
control C57BL/6 (B6) and IL-10-deficient (KO)
mice were included for comparison. Plasma IL-10
levels 15 days after LCMV Cl13 infection.
(C) Time course of IL-10 (GFP) expression in
multiple organs during acute (LCMV-Arm) and
persistent (LCMV-Cl13) infection.
(D) Bar graphs represent the percentage (upper
graphs) and number (lower graphs) of GFP-ex-
pressing cells at days 9 and 30 following acute or
persistent infection. Symbols represent individual
mice and are representative of three to five mice
per group and two or more independent experi-
ments. Error bars represent ± standard deviation
(SD) *p = < 0.05. See also Figure S1.
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Immunoregulatory APCs in Persistent Viral InfectionIL-10-Producing APCs Are Amplified in Persistent
Infection and Express Antigen Presentation and
Costimulation Machinery
To define the mechanisms of how IL-10 suppresses the immune
response to facilitate viral persistence, specific cell subsets that
exhibit enhanced IL-10 expression in persistent as compared to
acute infection were quantified. At the peak of IL-10 expression
in the spleen, multiple immune subsets produced IL-10,
including DCs, macrophages, B cells, and CD4+ and CD8+
T cells (Figure 2A). GFP-positive gates were again set using non-
transgenic B6 control mice (Figure S2). Interestingly, both
numerically and as a percentage, macrophages comprised the
highest amount of GFP+ (IL-10-producing) cells. Of note, the
level of IL-10-producing CD4 and CD8 T cells was similar at
the initial stages of acute and persistent infections, and the
vast majority of virus-specific T cells (i.e., tetramer positive) did
not produce IL-10. GFP expression was not observed in NK cells
or neutrophils (data not shown). While most of the cell subsets
contained IL-10-producing populations at day 9 postinfection,
the percent and number of IL-10-producing APCs (DCs, macro-
phages, and B cells) were substantially higher in persistentCell Host & Microbe 11, 481–4infection and continued to remain
elevated throughout viral persistence
(Figure 2B). Thus, although multiple cell
subsets produce IL-10 in response to
viral infection, there was a distinct differ-
ence in the regulation of APC populations
during acute and persistent infection.
DCs are required to initially activate
naive antiviral CD4+ and CD8+ T cell
responses in vivo (Jung et al., 2002;
Probst and van den Broek, 2005).
However, depletion of DCs after priming
(but before loss of T cell function)
following LCMV-Cl 13 infection did not
prevent T cell exhaustion (Figure S2).We previously demonstrated that T cells retain function when
removed from LCMV-Cl 13 infection at this same time (Brooks
et al., 2006a), indicating that as infection progresses, alternative
APCs in addition to DCs, such as macrophage and B cells, play
important regulatory roles tomodulate previously activated T cell
responses and adjust the immune response to the needs of the
evolving antigenic environment. Therefore, we next sought to
investigate the regulatory properties of IL-10-producing APCs
during persistent infection. The majority of IL-10-producing
DCs were CD11cbright, CD11bhi CD8 alo, B220neg, so we subse-
quently compared IL-10+ versus IL-10- DC within this subset;
however, a smaller yet evident population of CD11cbright,
CD11blo CD8 ahi, B220neg DC also produced IL-10 (Figure S2).
Of note, similar results as described below were observed
when IL-10+ versus IL-10- CD8+ DCs or total DCs were
compared (data not shown). IL-10-expressing B cells are not
limited to a single B cell subset and are observed in fractions
of plasma cells, memory cells, marginal zone cells, and germinal
center compartments (data not shown). Compared to their
non-IL-10-producing counterparts, IL-10-producing DCs,
macrophages, and B cells expressed equal if not enhanced91, May 17, 2012 ª2012 Elsevier Inc. 483
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Figure 2. Multiple APCSubsets Produce IL-10 in Persistent Infection
Flow plots depict GFP (IL-10) expression in Vert-X mice on (A) day 9 or (B) day
30 following LCMV-Cl 13 (top, black bars) or LCMV-Arm (bottom, white bars)
infection. Numbers indicate the percentage of GFP+ cells in each subset, and
graphs indicate the average percentage or number ±SD of GFP+ cells. Gating
strategy for each population is such that GFP signal is less than 1% in wild-
type C57BL/6 control mice (see Figure S1). *p < 0.05. Data are representative
of four mice per group and four independent experiments. See also Figure S2.
Cell Host & Microbe
Immunoregulatory APCs in Persistent Viral Infectionlevels of MHC class I and II proteins as well as the costimulatory
molecules CD80 (B7-1) and CD86 (B7-2) (Figures 3A–3C). The
small numbers of IL-10-expressing APCs present in acute infec-
tion (Figure 2) were of similar phenotype and DC subset distribu-
tion (Figures S2 and S3). Taken together, these results indicate
that IL-10-producing APCs are amplified in persistent infection
and represent mature populations capable of interacting with
and potentially modulating T cell responses.484 Cell Host & Microbe 11, 481–491, May 17, 2012 ª2012 Elsevier IIL-10-Producing APCs Simultaneously Express Multiple
Immunosuppressive Factors
Numerous regulatory mechanisms in addition to IL-10 have
evolved to restrain immune activity during persistent infection
(Wilson and Brooks, 2011). Exemplary of these are PD-1/PDL1
interactions and the critical role these host-derived proteins
play in sustaining T cell suppression in persistent viral infections
(Barber et al., 2006). Interestingly, both PDL1 and PDL2 were
significantly upregulated on all IL-10-expressing APC popula-
tions compared to their non-IL-10-producing counterparts (Fig-
ure 4A and Figure S4) and subsequently maintained throughout
the course of persistent infection (Figure 4A), suggesting that
multiple inhibitory factors may be centralized onto single iAPC
subsets.
To further explore the functions of iAPC populations, we as-
sessed expression of other immunosuppressive molecules
implicated in suppressing immune responses during persistent
infection. IDO dampens T cell responses via modulation of
tryptophan catabolism (Mellor and Munn, 2004). IDO expression
was substantially elevated in IL-10-producing DCs, macro-
phages, and B cells relative to their non-IL-10-producing
counterparts (Figure 4B). TGF-b is another immunoregulatory
cytokine recently indicated to limit antiviral T cell responses
and facilitate LCMV persistence (Tinoco et al., 2009). However,
unlike other immunosuppressive factors, iAPCs were not
enriched for TGF-b transcripts (Figure 4B), indicating that
iAPCs do not universally upregulate all immunosuppressive
genes important during viral persistence. APC production of
the potent proinflammatory cytokine IL-12 is a key component
in the induction of IFNg-producing T cell responses (O’Garra,
1998). RT-PCR analysis in iAPC subsets indeed revealed
a dramatic reduction in IL-12p35 levels when iAPCs were
compared to their non-IL-10-expressing counterparts (Fig-
ure 4B). Thus, in addition to increased expression of negative
regulatory factors, iAPCs also produced decreased levels of
positive stimulatory factors.
The increased expression of T cell-interacting proteins and
immunosuppressive factors in conjunction with lower levels of
stimulatory cytokines suggested that iAPCs in particular would
diminish instead of stimulate T cell responses. In accordance
with their inability to prime naive T cells, neither B cells nor
macrophages derived directly from persistent infection (regard-
less of IL-10 expression) were able to stimulate naive T cells
ex vivo (data not shown). However, consistent with their immu-
nosuppressive phenotype, iDC suppressed virus-specific T cell
responses ex vivo compared to their non-IL-10-producing coun-
terparts (Figure 4C and Figure S4). T cell-stimulatory capacity
was enhanced in iDC, but not non-iDC, when IL-10, PDL1, or
IDO signaling was blocked (Figure 4C and Figure S4). Thus,
iAPCs express concentrated levels of inhibitory molecules
with the ability to independently suppress virus-specific T cell
responses.
Immunoregulatory APC Maintenance and Amplification
Correlateswith Virus Replication Kinetics but Not Direct
Infection
Multiple immunosuppressive molecules are similarly upregu-
lated early in acute and persistent virus infection; however,
expression of these factors diminishes in an acute infection,nc.
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Figure 3. APCs Express Antigen Presentation and Costimulation
Machinery
Flow cytometric analysis comparing IL-10 producing (green) and non-IL-10
producing (black) in (A) DCs, (B) macrophages, and (C) B cells from the spleens
of Vert-X mice 9 days after LCMV Cl13 infection. Representative histogram
overlays between GFP+ (green) and GFP (black) cells are shown. The
corresponding bar graphs represent the geometric mean intensity (GMFI) ±SD
of four to five mice per group from one of three independent experiments.
*p < 0.05. See also Figure S3.
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Immunoregulatory APCs in Persistent Viral Infectionallowing T cells to maintain functionality (Barber et al., 2006;
Brooks et al., 2006b). Conversely, at the same time that negative
regulatory factors wane during acute infection, their expressionCell His sustained and amplified in persistent infection, promoting
T cell exhaustion and viral persistence (Figure 1A and Brooks
et al., 2006b; Ejrnaes et al., 2006). Yet, the reasons for the simul-
taneous sustained and increased expression of these multiple
factors are unclear. Interestingly, the expression kinetics of
iAPCs in acute and persistent infection parallels this course,
being initially equal when virus titers are similar (day 5) and
then waning to very low levels with decreased virus replication
in acute infection and expanding in conjunction with the
increasing virus replication in what will become a persistent
infection (Figure 5A). Inversely, levels of conventional (non-
IL-10-producing APCs) dramatically increased during acute
infection, whereas they remained low in response to prolonged
virus replication in persistent infection (Figure 5A). As the persis-
tent infection ensues, contraction of iAPCs mirrors the decrease
in virus titers (Figure 5A). Thus, iAPCs are invoked in response to
elevating virus expression, leading to sustained and heightened
expression ofmultiple immunoregulatory factors associatedwith
immune suppression during viral persistence.
Because of the tight correlation between viral load and iAPC
numbers, we sought to determine whether direct infection of
APCs was responsible in inducing the iAPC phenotype. While
there was a slight increase in the percentage of iAPCs that
were infected relative to their nonproducing counterparts, the
vast majority of iAPCs were not productively infected (Figure 5B
and data not shown), indicating that direct infection is not driving
the iAPC phenotype.
Immunoregulatory APCs Are Metabolically,
Transcriptionally, and Phenotypically Distinct
Recent studies have implicated an APC’s underlying metabolic
program in regulating fate and function. Oxidative metabolism
appears to be required for the acquisition of an anti-inflamma-
tory or immunoregulatory phenotype (Vats et al., 2006).
Conversely, TLR activation of canonical proinflammatory
programs in DCs requires a metabolic switch to aerobic glycol-
ysis (Krawczyk et al., 2010). Interestingly, IL-10 signals in-
hibited the acquisition of TLR-induced glycolytic programs in
APC (Krawczyk et al., 2010). To determine if this metabolic
paradigm was operative in the context of a persistent viral
infection, we quantified the mitochondrial membrane potential
of IL-10-producing and IL-10-negative macrophages, DCs,
and B cells on day 9 after LCMV-Cl 13 infection. Strikingly,
GFP+ macrophages, DCs, and B cells exhibited increased
MitoTracker Red staining relative to their GFP counterparts
ex vivo, indicating higher mitochondrial membrane potential
(Figure 6A).
The increased mitochondrial potential in IL-10-producing
APCs could be indicative of a heightened oxidative metabolic
state or the result of increased mitochondrial mass. To distin-
guish between these two possibilities, we quantified expression
of the mitochondrially encoded gene cytochrome c oxidase II
(Mt-co2) relative to the nuclear housekeeping gene nuclear
receptor-interacting protein 1 (Rip140). The ratio of Mt-co2 to
Rip140 was not statistically different between IL-10-producing
and IL-10-negative DCs and macrophages (Figure 6B), sug-
gesting an equivalent mitochondrial mass in both populations
of APCs. The metabolic state of IL-10-producing B cells is
less clear, as Mt-co2 levels are significantly elevated in theseost & Microbe 11, 481–491, May 17, 2012 ª2012 Elsevier Inc. 485
dendritic cells macrophages B cells
p
e
rc
e
n
t 
m
a
x
.
0 10
3
10
4
10
5
0 10
3
10
4
10
5
dendritic cells macrophages B cells
60
40
20
0 0
* *
- + - + - +
G
M
F
I 
(x
1
0
2
)
G
M
F
I
A
B
re
la
ti
v
e
 e
x
p
re
s
s
io
n
 (
x
1
0
2
)
- +
DC
- +
indoleamine 2,3 dioxygenase
- +
mac B cells
40
4
20
0
3
2
1
DC
TGFβ
- + - + - +
mac B cells
150
0
100
50
IL-12
- +
DC
- + - +
mac B cells
150
1500
0
1000
200
100
50
0
20
40
60
80 *
- +
day 9
0 10
3
10
4
10
5
- +
100
0
- +
300
200
200
0
600
400
**
300
200
100
PDL1
p
e
rc
e
n
t 
m
a
x
.
0 10
3
10
4
10
5
- +
*
60
40
20
0
0 10
3
10
4
10
5
0 10
3
10
4
10
5
10
7.5
5
2.5
0
*
- +
*20
15
10
5
0
0 10
3
10
4
10
5
PDL2
- +
*
400
300
200
100
0
G
M
F
I
0 10
3
10
4
10
5
- +
200
0
600
400
*
0 10
3
10
4
10
5
day 30
- +
0
300
200
100
*
PDL1 PDL2
PDL1 PDL2
0 10
3
10
4
10
5
0 10
3
10
4
10
5
0 10
3
10
4
10
5
0 10
3
10
4
10
5
media αIL-10R
CFSE
p
e
rc
e
n
t 
m
a
x
.
90
0
60
30
media aIL-10R
- + - +
n
u
m
b
e
r 
d
iv
id
e
d
S
M
A
R
T
A
 (
x
1
0
2
)C
Media aIL10 aPDL1 1MT
20
40
60
80
100
0S
ti
m
u
la
ti
o
n
 I
n
d
e
x
D
50
40
30
0
10
20
- + - +- +
media aPDL1 1MT
n
u
m
b
e
r 
d
iv
id
e
d
S
M
A
R
T
A
 (
x
1
0
2
)
0 10
3
10
4
10
5
*
- +
G
M
F
I 
(x
1
0
2
)
0
20
40
60
80
Figure 4. iAPCs Simultaneously Express
Multiple Immunoregulatory Molecules and
Have Reduced Stimulatory Capacity
(A) Flow cytometric analysis of GFP+ (green) and
GFP (black) splenic DCs (CD11b+), macro-
phages, and B cells from Vert-X mice on days 9
and 30 after LCMV Cl13 infection. Representative
histogram overlays of PDL1 (left) and PDL2 (right)
of cells. Bar graphs represent the GMFI ±SD of
PDL1 and PDL2 expression by the indicated APC
subset; *p < 0.05.
(B) mRNA expression of indoleamine 2,3 dioxy-
genase (right), TGF-b (middle), and IL-12 (left)
relative to HPRT in the indicated IL-10+ (GFP+) or
IL-10 (GFP) APC subset on day 9 after LCMV
Cl13 infection. Each group is a pool of cells from
six to eight mice and is representative of two or
more independent experiments.
(C) GFP+ (CD11b+) DCs (green histogram) or
GFP- (CD11b+) DCs (black histogram) were
sorted from the spleens of day 9 LCMV Cl13-
infected Vert-X mice and cultured for 3 days with
naive CFSE-labeled TCR transgenic, LCMV-
specific CD4+ (SMARTA) T cells in either media
alone or with the addition of anti-IL-10R blocking
antibody. Bar graphs represent the number of
SMARTA cells that divided in cultures containing
media alone or anti-IL-10R, anti-PDL1, or the IDO
inhibitor 1-MT. The separate bar graphs repre-
sent independent experiments. Each condition
is representative of at least two independent
experiments.
(D) Stimulation index indicates the total number of
SMARTA T cells that proliferated in the cultures
with GFP+ (CD11b+) DCs divided by the number
of CD4+ SMARTA T cells that proliferated in the
GFP culture in the presence of media alone or
of anti-IL-10R, anti-PDL1, or 1MT (a chemical
inhibitor of IDO). Each group is a pool of cells
from six to eight mice and is representative of two
or more independent experiments. *p < 0.05. See
also Figure S4.
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Immunoregulatory APCs in Persistent Viral Infectionpopulations—indicating an increase in mitochondrial number as
well as potential. We further examined the expression levels of
key glycolytic genes. IL-10-producing macrophages expressed
markedly lower levels of the glycolysis genes hexokinase 2
(HK2), lactate dehydrogenase A (Ldha), and pyruvate kinase
(Pkm2) (Figure 6C), indicative of an oxidative/suppressive meta-
bolic program. Interestingly, GFP+ and GFP DC populations
expressed similar levels of the glycolysis genes, suggesting
a complex metabolic regulation. Hence, iAPCs are metaboli-
cally distinct subsets of cells that simultaneously express
multiple immunoregulatory factors with heightened suppressive
activity.
The metabolic, phenotypic, and functional attributes of the
immunoregulatory macrophages that arise during infection are
consistent with those of M2/alternatively activated macro-
phages (Lawrence and Natoli, 2011). The IL-10-expressing
macrophages induced during persistent viral infection express
low levels of GR1 (correlating with M2 development; Lin et al.,
2009) and are highly enriched for the M2-associated transcripts
Arg1 and CD206 (Figure 6D). iAPC populations also exhibit
a distinct molecular profile. Interferon-regulatory factors (IRFs)486 Cell Host & Microbe 11, 481–491, May 17, 2012 ª2012 Elsevier Icomprise a family of signaling molecules that play important
roles in the regulation of M2 macrophage polarization and DC
ontogeny (Savitsky et al., 2010; Satoh et al., 2010). Expression
of IRF4 is significantly elevated in IL-10-producing macro-
phages and DCs, whereas expression of the related inter-
feron-regulatory factor IRF3 is similar compared to IL-10
nonproducers (Figure 6E). B-lymphocyte-induced maturation
protein 1 (Blimp-1) is a transcriptional repressor in T and B
cell development (Xin et al., 2011), promotes IL-10 production,
and is linked to maintenance of tolerogenic DC populations
(Chan et al., 2009; Kim et al., 2011; Martins et al., 2006).
Interestingly, Blimp1 expression was highly elevated in IL-10-
expressing, compared to nonexpressing, DCs and macro-
phages (Figure 6E). In accordance with the antagonism
between Bcl6 and Blimp1, Bcl6 expression was decreased in
iAPCs (Figure 6E). Thus, persistent infection promotes the
amplification of iAPC populations with distinct molecular and
metabolic profiles that simultaneously express multiple immu-
nosuppressive and T cell-modulating factors (IL-10, PDL1,
PDL2, B7-1, B7-2, and IDO) capable of negatively regulating
antiviral T cell activity.nc.
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Figure 5. iAPCS Tightly Correlate with Levels of Virus Replication
but Are Not Directly Infected
(A) Quantification of total IL-10-expressing APCs (DCs, macrophages, and B
cells) compared to virus replication kinetics in acute LCMV-Arm (black and
gray lines) and LCMV-Cl 13 (red and pink lines) infection. Data are represen-
tative of four to fivemice per group and two or more independent experiments.
*p < 0.05 comparing number of iAPCs in LCMV-Arm versus LCMV-Cl13
infection. **p < 0.05 comparing virus titers in LCMV-Arm versus LCMV-Cl13
infection. Error bars represent ±SD.
(B) IL-10-expressing DCs, macrophages, and B cells were FACSorted, and the
percent of each population infected was quantified. Data are representative of
pools of six mice per group and two independent experiments.
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Immunoregulatory APCs in Persistent Viral InfectionDISCUSSION
Activation of effective CD4 and CD8+ T cell responses in the face
of persistent viral infection is a major therapeutic goal. However,
the multiple immunoregulatory pathways that are elevated and
sustained during persistent infection, resulting in T cell suppres-
sion, must be overcome while not engendering widespread
immunopathology. In this study we demonstrate that many
immune cell types simultaneously produce IL-10, potentially all
playing important and distinct roles in suppressing the host
immune response. Interestingly, within each APC population we
identified a distinct subset that coexpressed many of the domi-
nant factors implicated in suppressing T cell responses in viral
persistence. These iAPC subsets have similarities to other previ-
ouslydescribedpopulations (i.e.,M2macrophages) that canarise
during other states of chronic inflammation. Importantly, these
specialized iAPCs are dramatically amplified during persistent
infection and peak during the transition into T cell dysfunction.
Our results demonstrate that invocation of iAPCs is a funda-
mental andpreviously unrecognized response to viral replication.
Paradoxically, the same inhibitory factors that are responsible forCell Hinducing viral persistence are also present early in acute infec-
tion, but then rapidly disappear to facilitate productive T cell
responses (Figure 1A, Figure 5A, and Barber et al., 2006; Brooks
et al., 2006b). On the other hand, these same factors are sus-
tained and amplified in what will become a persistent infection,
promoting immune suppression and viral persistence. Thus, an
inflection point exists when the immune response determines
whether it is winning or losing the battle with viral replication
and then adjusts itself accordingly. Interestingly, dynamic regula-
tion of iAPC at the inflection point between virus clearance and
persistence clarifies the enigmatic expression kinetics ofmultiple
inhibitory factors. Based on the important role of these multiple
inhibitory factors in inducing and maintaining T cell/immune
exhaustion, the coexpression of these molecules by single cells
that can themselves be rapidly regulated is a mechanism
whereby the immune response can be quickly adjusted to appro-
priately modulate aggressive immunity when the battle is being
won, with suppressive responses that prevent excessive immu-
nopathology when the battle is lost. However, the immune
response is not binary (i.e., vigorous effector responses or
complete exhaustion), and by varying the levels of iAPCs, it
may be possible to achieve the spectrum of T cell (and overall
immune) quality/quantity required to fight a given pathogen.
Importantly, targeting of these cells may represent an effective
therapeutic approach to delete immunosuppressive cells while
maintaining stimulatory APCs to sustain ongoing immune
responses.
iAPCs exhibit a separate molecular, metabolic, phenotypic,
and functional profile compared to their conventional APC coun-
terparts residing in the sameenvironment, indicating that they are
a distinct group of cells that naturally arise during viral infection
and are specifically and dramatically amplified in response to
persistent infection. Further, despite belonging to different APC
cell types (i.e., DCs, macrophages, B cells), the similar molecular
profile of iAPCs suggests that they may share common triggers
and differentiation programs in response to ongoing virus replica-
tion. The direct correlation of iAPC numbers with virus replication
kinetics suggests that iAPCs may not be sustained individually
long-termasmuchascontinually stimulated.Basedon theknown
plasticity of macrophages (and potentially DCs, either through
functional modification or rapid turnover), it is possible that
APCs are continually recruited into the immunoregulatory subset
to appropriately modulate the current needs of the immune envi-
ronment. However, the fact that blockade of IL-10, PDL1, and
other negative regulatory factors successfully enhances effector
T cell responses during persistent infection indicates that these
iAPC populations continue to have an important immune-modu-
latory role throughout the course of such infections.
The concurrent blockade of multiple suppressive signals addi-
tively enhances antiviral T cell activity (Blackburn et al., 2009;
Brooks et al., 2008; Jin et al., 2010), suggesting the existence
of a threshold level of duration and/or strength of signals that
must be reached by a particular cell to initiate the exhaustion
program. It is important to note that inhibitory factors may
possess different levels of activity during persistent infection.
In vivo inhibition of IL-10 or PDL1 can prevent or decrease
persistent virus replication, while blockade of other immunoreg-
ulatory molecules in vivo such as CTLA4 have less obvious
impact (Barber et al., 2006; Kaufmann et al., 2007), potentiallyost & Microbe 11, 481–491, May 17, 2012 ª2012 Elsevier Inc. 487
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Figure 6. IL-10-Expressing APCs Have
Altered Metabolic Programs
(A) Mitochondrial membrane potential assessed
by MitoTracker FM RED staining of IL-10+ or
IL-10 macrophages, DCs, and B cells on day 9
after LCMV Cl13 infection. Black histograms/bars
are IL-10, and green histograms/bars are IL-10+
subsets. Data are representative of four to five
mice per group and three separate experiments.
(B) Ratio of mitochondrial Mt-co2 to nuclear
Rip140 gene expression from purified IL-10+ or
IL-10 macrophages, DCs, and B cells on day 9
after LCMV Cl13 infection.
(C) Expression of the glycolysis genes pyruvate
kinase (Pkm2), lactate dehydrogenase A (Ldha),
and hexokinase 2 (HK2) on day 9 after LCMV Cl13
infection.
(D) The histogram illustrates GR1 expression, and
the bar graphs represent the expression of M2/
alternatively active genes Arginase 1 and CD206
by IL-10+ (green) and IL-10 (black) macro-
phages. Error bars represent ±SD.
(E) Expression of the signaling/transcription
factors IRF4, IRF3, Blimp1, and BCL6 by the indi-
cated APC populations. Each group is a pool of
cells from six to eight mice and is representative of
five independent experiments. *p < 0.05.
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Immunoregulatory APCs in Persistent Viral Infectionserving to fine-tune the ongoing response. Thus, immunosup-
pression is a multifactorial process in which many factors
contribute to varying degrees (likely through targeting different
cells and distinct cellular functions) to cumulatively restrain
immune activity (Blackburn et al., 2009). By this mechanism,
the clustering of multiple immunoregulatory factors on iAPCs
provides a method for rapid delivery of numerous potent inhibi-
tory signals directly to individual T cells.
Antibody blockade of IL-10, PDL1, or other factors during
persistent infections enhances T cell activity (Barber et al.,
2006; Brooks et al., 2006b; Ejrnaes et al., 2006; Fahey and
Brooks, 2010). This underscores the fact that maintenance of
exhaustion as an active process and that dynamic alterations488 Cell Host & Microbe 11, 481–491, May 17, 2012 ª2012 Elsevier Inc.in postpriming immune environment are
critical modulators of T cell activity. In
addition to IL-10-expressing DCs, we
also identified the emergence of B cells
and a large percentage of macrophages
that express IL-10 in concert with many
other inhibitory factors that suppress anti-
viral immunity during persistent infection.
When T cells are removed after priming,
but prior to loss of function, from what
will become a persistent infection, they
retain effector activity and differentiate
into memory cells (Brooks et al., 2006a).
Paralleling this, our finding that DC dele-
tion after priming, but before loss of
T cell activity, does not prevent T cell
exhaustion indicates that multiple iAPC
populations modulate ongoing T cell
responses to potentiate T cell exhaustion.Consequently, while not capable of priming naive T cells, IL-10-
expressing macrophages and B cells likely play critical roles as
infection progresses. In this manner, IL-10-expressing macro-
phages and B cells express high levels of MHC molecules,
fostering their ability to interact with T cells. How each of these
iAPCs targets distinct aspects of the immune response to
promote persistent infection is undoubtedly complex, but will
ultimately be of tremendous importance for the development of
targeted therapies to overcome the mechanisms viruses utilize
to subvert immune clearance.
Studies examining the metabolic programs adopted by APCs
in the context of infection and immunity are limited. Elegant
studies by Chawla and colleagues demonstrated that expression
Cell Host & Microbe
Immunoregulatory APCs in Persistent Viral Infectionof an oxidative metabolic program was an absolute requirement
for the polarization of M2 or alternatively activated macrophages
in chronic inflammatory models (Vats et al., 2006). In contrast,
activation ofDCsbyproinflammatory signals inducesametabolic
switch from oxidative to glycolytic metabolism which, if pharma-
cologically inhibited, alters T cell-stimulatory capacity (Krawczyk
et al., 2010). In our study, we observed that IL-10-producing
macrophages have significantly higher membrane potential
(with no appreciable change in mitochondrial mass and
decreased glycolytic gene expression) relative to their IL-
10-negative counterparts, indicative of an oxidative metabolic
program. Further, IL-10-expressing macrophages also ex-
pressed high levels of multiple phenotypic and molecular factors
associated withM2/alternatively activatedmacrophage differen-
tiation. Unlike acute LCMV infection, during persistent LCMV
infection, these macrophages represent a high proportion of the
total macrophage population, suggesting a high likelihood that
any interaction between a T cell and macrophage will include
these regulatory macrophages and result in the delivery of
multiple potent inhibitory signals that decrease antiviral
responses in order to limit immunopathology. Interestingly, these
data support the concept that emergence of oxidative, regulatory
macrophages is ageneral featureof chronic inflammatory events.
IL-10-expressing DCs similarly exhibit increased mitochon-
drial membrane potential with no notable change in mitochon-
drial mass. In vitro studies demonstrated an antagonistic role
for IL-10 in the acquisition of the glycolytic program in response
to TLR signaling. However, we did not find significant differences
in the glycolytic program of IL-10-positive and -negative DCs
and B cells in vivo, suggesting that IL-10 signals may not directly
suppress glycolytic gene expression in these cells. Alternatively,
IL-10 signaling may similarly suppress the glycolytic program in
both IL-10-expressing and -nonexpressing DCs and B cells.
Importantly, our study identifies a metabolic and gene expres-
sion pathway associated with naturally arising iAPCs during
a persistent infection.
The tight correlation of iAPCs with viral titers and their similar
molecular/transcriptional profiles suggests the existence of
specific host sensors of viral replication that, in turn, regulate
execution of the iAPC differentiation program. Direct targeting
of iAPCs, or such sensors, may provide a potent therapeutic
strategy for rapidly and specifically dampening suppressive
signals and bolstering T cell responses during viral persis-
tence—without perturbing more global regulatory processes. A
further understanding of how iAPCs are generated, and the
mechanisms by which they modulate T cell activity, may facili-
tate development of therapeutic strategies for the restoration
of immune responses during persistent infection.EXPERIMENTAL PROCEDURES
Mice, Virus, and DT Administration
C57BL/6 (wild-type), IL-10-deficient, and CD11c-DTR mice were purchased
from The Jackson Laboratory (Bar Harbor, ME). Vert-X, LCMV-GP61-80-
specific CD4+ TCR transgenic (SMARTA) and the IL-10/Thy1.1 (10BiT)
reporter mice (generously provided by Casey Weaver at the University of
Alabama, Birmingham [via Gislaine Martins at Cedars-Sinai Medical Center,
Los Angeles, CA]) have been described previously (Madan et al., 2009;
Maynard et al., 2007; Oxenius et al., 1998). All mice were housed under
specific pathogen-free conditions, and mouse handling conformed to theCell Hrequirements of the University of California, Los Angeles, Animal Research
Committee guidelines. In all experiments mice were infected intravenously
(i.v.) via the retro-orbital sinus with 2 3 106 plaque-forming units (PFUs) of
LCMV-Arm or LCMV-Cl 13. Virus stocks were prepared and viral titers were
quantified as described previously (Brooks et al., 2005). The frequency of
productively infected IL-10-expressing splenic DCs (GFP+, CD45+, CD3–,
NK1.1–, CD11c+), B cells (GFP+, B220+), and macrophages (GFP+, CD45+,
CD3–, NK1.1–, CD11c–, F4/80+) was determined by FACSorting the individual
population and performing limiting dilution plaque assays (infectious center
assays) on Vero cells (Brooks et al., 2006a). Diphtheria toxin (100 ng) (List
Biological Laboratories, Campbell, CA) was administered intraperitoneally
on days 5 and 7 after LCMV-Cl 13 infection.
Bone Marrow Chimera Experiments
C57BL6 or IL-10-deficient recipient mice were lethally irradiated with 950 rads
and on the same day received 20 million total bone marrow cells intravenously
isolated from the femurs and tibia of either IL-10-deficient or WT donor mice.
Recipient mice were treated with antibiotics (Sulfamethoxazole and Trimetho-
prim in the drinking water) for 3 weeks to prevent infection and allow for
hematopoietic reconstitution. Eight weeks following bone marrow transfer,
mice were bled to confirm consistent reconstitution and then infected with
LCMV Cl13.
Flow Cytometry
Analysis of IL-10-expressing (GFP+) and nonexpressing (GFP) cells was
performed by staining directly ex vivo for surface expression of CD45-Pacific
Orange or Pacific Blue; CD11c-Pacific Blue or PE; Thy1.1-FITC or PE;
Thy1.2-PerCP, NK1.1-PerCPCy5, B220-APCCy7, CD11bPeCy7, F4/80-PE,
or APC; PDL1-PE or biotin followed by streptavidin-APC, PDL2-PE, MHC
Class II-PE, MHC Class I-PE, CD80-PE, CD86-PE, CD4-Pacific Blue,
CD8-Pacific Blue. Mitochondrial membrane potential was accessed by stain-
ing with MitoTracker FM Red (Invitrogen) according to the manufacturer’s
instructions. MHC tetramers were obtained from the National Institutes of
Health (NIH). Flow cytometric analysis was performed using the Digital LSR
II (Becton Dickinson) in the UCLA Jonsson Comprehensive Cancer Center
(JCCC)/Center for AIDS Research Flow Cytometry Core Facility (NIH grant
CA-16042).
Purification of APC Populations
IL-10-producing and nonproducing DCs and macrophages were sorted from
spleen following B cell depletion (CD19 MACS beads, Miltenyi) as follows:
IL-10-expressing DCs (GFP+, CD45+, Thy1.2, NK1.1, CD11c+ bright,
CD11b+), non-IL-10-producing DCs (GFP, CD45+, Thy1.2, NK1.1,
CD11c+ bright, CD11b+), IL-10-expressing macrophages (GFP+, CD45+,
Thy1.2, NK1.1, F4/80+), and non-IL-10-producing macrophages
(GFP, CD45+, Thy1.2, NK1.1, F4/80+). The depleted B cell (CD19+)
fraction was subsequently sorted for IL-10-producing (GFP+, CD45+,
Thy1.2, NK1.1, B220+) and nonproducing (GFP, CD45+, Thy1.2,
NK1.1, B220+) populations. Cells were sorted using a FACS Aria or
Vantage fluorescence-activated cell sorter (Becton Dickinson). Postsort
purity was >98%.
Quantitative RT-PCR
RNA purified from whole splenocytes or sorted APC populations was isolated
with the RNeasy Extraction Kit (QIAGEN). RNA was normalized for input and
amplified directly using the One-Step RT-PCR Kit (QIAGEN). IDO, TGF-b,
IL-10, IL-12, Blimp1, IRF4, IRF3, BCL6, and HPRT were amplified using
Applied Biosystems Assays-on-Demand TaqMan premade expression
assays. IDO, TGF-b, and IL-12 expression were normalized to HPRT. Meta-
bolic gene expression was determined from cDNA with the exception that
SYBR Green (Roche) real-time quantitative PCR assays were performed using
the Roche Light cycler 480 II (Roche). Genes are normalized to ribosomal
housekeeping gene Rip140. The primer sequences for the metabolic genes
are available upon request.
In Vitro T Cell Stimulation
Antigen-specific naive CD4+ T cells or CD8+ T cells were isolated from the
spleens of SMARTA or P14 mice, respectively, and purified by negativeost & Microbe 11, 481–491, May 17, 2012 ª2012 Elsevier Inc. 489
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Immunoregulatory APCs in Persistent Viral Infectionselection (StemCell Technologies). T cells were then labeled with 2.5 uMCFSE
(Invitrogen) and cultured for 3 days with sorted populations of IL-10-producing
(GFP+) or non-IL-10-producing (GFP) APCs at a ratio of 2:1 (40,000 T cells/
20,000 APC). In some situations, 10 mg/ml anti-IL10R antibody (clone 1B1.3A;
BioXcell) or anti-PDL1 antibody (clone 1F.9G2, BioXcell), or 200 mM 1-methyl
tryptophan (1-MT; Sigma-Aldrich) was added to the cultures. The frequency of
SMARTA or P14 cells that proliferated during culture was determined as
described (Gett and Hodgkin, 2000). Briefly, the number of cells in each divi-
sion peak was divided by 2i (where i equals the number of divisions). The total
number of SMARTA cells in each peak was then summed, and this number
was divided by the total number of SMARTA cells in the culture. This number
was then expressed as the percent of cells that had proliferated. To obtain the
stimulation index, the total number of T cells that proliferated in the cultures of
GFP+ culture was divided by the number of T cells that proliferated in the
GFP culture, multiplied by 100.
ELISA
Plasma IL-10 levels were determined using the Quantikine IL-10 Elisa kit (R&D
Systems, Minneapolis, MN). Optical density values were read using a Synergy
2 plate reader (BioTek, Winooski, VT) at 450 nm.
Statistical Analysis
Student’s t tests (two-tailed, unpaired) were performed using the GraphPad
Prism 5 software (GraphPad Software Inc.).
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